GSTO1 and Alzheimer disease: APOE ε4 stratification revealed significant changes in the distribution of the two GSTO1 protein spots A1998 and A2000 in APOE ε4-positive and APOE ε4-negative AD patients (Fig. OR3; Table OR2).